Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Isoliquiritin apioside

Cat. No.: IBDI-430257

Isoliquiritin apioside significantly decreases PMA-induced increases in MMP9 activities and suppresses PMA-induced activation of MAPK and NF-κB. Isoliquiritin apioside auppresseses invasiveness and angiogenesis of cancer cells and endothelial cells.

Size (Solid):

Product Details

Target NF-κB | MMP | p38 MAPK
Molecular Weight 550.51
Appearance Solid
SMILES O=C(C1=C(C=C(O)C=C1)O)/C=C/C(C=C2)=CC=C2O[[email protected]](O[[email protected]](CO)[[email protected]@H](O)[[email protected]@H]3O)[[email protected]]3([H])O[[email protected]]4[[email protected]@H]([[email protected]](CO)(O)CO4)O
Structure Classification Flavonoids>Chalcones
Phenols>Polyphenols
Purity 99.87%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.